Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-HLA Immunization in Liver Retransplantation (DSATH)
NCT02556879Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2016
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Risk of graft failure at 24 months depending on the presence of DSA at retransplantation. Status: unknown.
Beyond the preview
Go deeper on NCT02556879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02556879.